"A lot of thought has gone into RNA vaccines, and they've actually been studied in clinical trials for many years now for cancer and other infectious diseases," says Dr. John Cooke, medical director of the RNA Therapeutics Program at Houston Methodist.
Read More
The Southern Nevada Health District is administering COVID-19 vaccine in coordination with the Nevada State Immunization Program and State Public Health Preparedness staff. The vaccine is being received in limited supplies. A phased distribution ensures there is equitable access to the vaccine by the critical populations identified by the Centers for Disease Control and Prevention (CDC).
January 20-23, 30
Southern Nevada Health District
280 S. Decatur Blvd.
Las Vegas, NV 89107
Appointment availability opens up to 7 days in advance.
mRNA vaccines are a new type of vaccine to protect against infectious diseases. To trigger an immune response, many vaccines put a weakened or inactivated germ into our bodies. Not mRNA vaccines. Instead, they teach our cells how to make a protein—or even just a piece of a protein—that triggers an immune response inside our bodies. That immune response, which produces antibodies, is what protects us from getting infected if the real virus enters our bodies.
https://primarycaredoctorlasvegas.com
So far, none of the vaccine trials have reported any serious safety concerns. Trials for the first two vaccines — from Pfizer and Moderna — have had fully independent safety monitoring boards, and safety data are continuously reviewed by the FDA and expert panels.
Allergies: The CDC says people with allergies to certain foods, insects, latex and other common allergens can have the COVID-19 vaccine. Those with a history of severe allergic reaction (anaphylaxis) to injectables or other vaccines should discuss the vaccination with their doctor, who can evaluate the person and assess their risk. According to the CDC, at this time, anyone who has a severe allergy (e.g., anaphylaxis) to any of the Pfizer/BioNTech vaccine ingredients should not receive this vaccine. https://primarycaredoctorlasvegas.com
Trial participants who received Moderna's COVID-19 vaccine still had elevated antibodies three months after their second dose, according to data published in a letter to the editor of the New England Journal of Medicine.
The data, published Dec. 4, showed that all 34 participants who received the vaccine in Moderna's phase 1 trial had antibodies that declined over time but remained high three months after receiving their second dose.
"These data give us further optimism to expect that the high level of efficacy recently demonstrated by mRNA-1273 to prevent COVID-19 disease will be durable," Tal Zaks, MD, PhD, Moderna's chief medical officer, said in a press release.
Moderna's vaccine, called mRNA-1273, is administered in two shots 28 days apart. It will be reviewed by the FDA Dec. 17 and could receive emergency use authorization shortly thereafter. https://primarycaredoctorlasvegas.com
NIAID Director Anthony S. Fauci, M.D., gets a seasonal influenza vaccine every year. In a new video, he explains why getting the flu shot is so important for individual health and to prevent the spread of influenza virus. Each year, seasonal influenza sickens millions and causes thousands of hospitalizations and flu-related deaths. Even healthy people can get very sick from the flu and spread it to others. The Centers for Disease Control and Prevention recommend a yearly flu vaccine for everyone six months and older. Dr. Fauci also shares other tips for avoiding the flu this winter, such as staying away from crowded areas and washing hands frequently.